Wave Life Sciences Quarterly Balance Sheet
NASDAQ: WVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Wave Life Sciences financial position
As of Jun 30, 2026, Wave Life Sciences reported total assets of $558.3 million, up 121.2% from a year earlier against total liabilities of $104.8 million. Shareholders' equity stood at $453.5 million, or 81.2% of assets. The company held $368.0 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 9.99, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Wave Life Sciences balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 368.01M | 544.59M | 602.07M | 196.22M | 208.48M | 243.07M | 302.08M | 310.95M | 153.96M | 180.92M | 200.35M | 139.94M |
| Receivables | 888.00K | 0 | 1.28M | 10.00M | 1.62M | — | 1.42M | 0 | 1.29M | 0 | 21.09M | 7.00M |
| Total Current Assets | 507.51M | 561.27M | 614.81M | 215.49M | 223.56M | 257.98M | 320.39M | 324.51M | 172.07M | 196.77M | 235.37M | 158.57M |
| Property, Plant & Equipment | 6.83M | 7.08M | 7.41M | 8.20M | 9.04M | 9.57M | 10.13M | 10.93M | 11.78M | 12.42M | 13.08M | 13.77M |
| Total Assets | 558.32M | 583.54M | 638.50M | 241.38M | 252.35M | 288.34M | 352.21M | 358.50M | 208.82M | 235.27M | 274.95M | 199.92M |
| Accounts Payable | 20.36M | 19.06M | 15.70M | 14.49M | 14.66M | 14.36M | 16.26M | 12.78M | 18.15M | 11.73M | 12.84M | 12.61M |
| Total Current Liabilities | 50.81M | 49.83M | 95.06M | 85.90M | 87.41M | 87.37M | 110.95M | 170.73M | 173.13M | 165.87M | 186.44M | 99.98M |
| Total Liabilities | 104.80M | 71.81M | 112.27M | 108.95M | 105.22M | 108.67M | 134.82M | 208.99M | 204.42M | 202.01M | 227.44M | 232.53M |
| Shareholders' Equity | 453.52M | 511.73M | 518.36M | 124.55M | 139.27M | 171.80M | 209.51M | 141.64M | -3.48M | 25.39M | 39.63M | -40.49M |
| Retained Earnings | -1.42B | -1.35B | -1.33B | -1.27B | -1.22B | -1.17B | -1.12B | -1.15B | -1.09B | -1.06B | -1.02B | -1.01B |
| Net Cash (Debt) | 368.01M | 544.59M | 602.07M | 196.22M | 208.48M | 243.07M | 302.08M | 310.95M | 153.96M | 180.92M | 200.35M | 139.94M |
| Shares Outstanding | 193.28M | 192.34M | 187.66M | 160.29M | 155.67M | 154.09M | 153.04M | 148.39M | 122.48M | 122.32M | 119.16M | 99.01M |
This table shows 12 quarterly periods of Wave Life Sciences's balance sheet, from Q2 2026 back to Q3 2023, across 13 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow WVE's reporting calendar. What is a balance sheet?